Navigation Links
Advantages of Singapore as a Clinical Supply Hub to be Discussed by Catalent at Accelerating Clinical Trials in Asia Conference
Date:9/17/2019

Catalent, a global leader in clinical supply services, today announced that Julie Delaney, Director, Project and Clinical Supplies Management, Asia Pacific (APAC) will present at the upcoming 3rd Annual Accelerating Clinical Trials in Asia, at the One Farrer Hotel, Singapore, on Sept. 25-26, 2019.

On Thursday, Sept. 26, at 10:10 a.m., Ms. Delaney will present “Singapore: APAC’s Clinical Supply Gateway to the World.” She will explain the economic and regulatory advantages of locating a clinical supply hub in Singapore and will also discuss the importance of clinical supply management in optimizing drug development and launch strategy, ensuring trials are executed on time.

Ms. Delaney has more than 25 years’ experience in clinical supplies management, with over 10 years spent in the APAC region. She has held several roles in supplies management and quality assurance for several pharmaceutical companies and contract manufacturing organizations. In her current role, Ms. Delaney is responsible for Catalent’s project management teams in Singapore, China and Japan.

For further information, visit http://www.clinical.catalent.com/events/accelerating-clinical-trials-in-asia-ibc.

About Catalent
Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. Catalent employs nearly 13,000 people, including approximately 2,400 scientists, at more than 35 facilities across five continents, and in fiscal year 2019 generated over $2.5 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit http://www.catalent.com.

More products. Better treatments. Reliably supplied.™

Read the full story at https://www.prweb.com/releases/advantages_of_singapore_as_a_clinical_supply_hub_to_be_discussed_by_catalent_at_accelerating_clinical_trials_in_asia_conference/prweb16576861.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology technology :

1. Advantages of Piezoelectric Actuators in Haptic Feedback
2. Bruce Wiley Joins the Executive Team at FamilyFarms Group as Managing Director of Competitive Advantages
3. New Charm Peel Plate EC Offers Significant Advantages in Traditional Coliform Count Testing — Awarded AOAC-RI Performance Test Method Status
4. New England Biolabs opens seventh subsidiary in Singapore
5. RAPS Opens Offices in Singapore and China
6. Singapore Focus Chemistry Launches New Website, Www.FocusChemistry.Com, Targeting A Level Chemistry Students
7. Nanotechnology experts to gather in Singapore for 3rd Nano Today Conference
8. Singaporean university launches worlds 1st ZigBee-based inter-satellite comms system
9. NTU Singapore lights up photonics research with $100 million institute
10. Global Stem Cells Group Announces Agreement with Singapore Stem Cell Training Network
11. Healy Consultants Releases New Singapore Incorporation Guide for Foreigners as the Country Transformed into a Strong Digital Hub & a Launch Pad for New Emerging Economies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/18/2019)... Fla. (PRWEB) , ... December 18, 2019 , ... Tune ... of Advancements, hosted by Ted Danson. Check local listings for more information on this ... innovations in augmented reality are helping to simplify complex system to increase the efficiency, ...
(Date:12/6/2019)... ... December 06, 2019 , ... ... Inc. has received FDA 510(k) clearance for its latest CAPERE® Thrombectomy System ... data suggests the CAPERE® offers great benefits for first-in-line treatment for nonsurgical ...
(Date:12/4/2019)... ... 03, 2019 , ... Absolute Antibody Ltd. , an ... the Recombinant Antibody Network (RAN), a consortium of three expert centers at the ... common goal to generate recombinant antibodies at a proteome-wide scale. Under the new ...
(Date:12/4/2019)... ... December 03, 2019 , ... A new study released today ... reduce and even reverse fibrosis (scar tissue) buildup – also improves the range of ... of Medicine, was conducted on mice. , The tumor-destroying capabilities of radiation therapy ...
Breaking Biology Technology:
(Date:12/23/2019)... , ... December 23, 2019 , ... ... amorphous material is relatively straight-forward, but the reverse situation can be quite daunting. ... Improved Pharma describes some of these approaches and announces advances of their own ...
(Date:12/18/2019)... Mass. (PRWEB) , ... December 17, 2019 , ... ... R. Murrow Center for a Digital World at The Fletcher School, Tufts University, ... that will enhance the digital learning experience of students using Macmillan Learning’s acclaimed ...
(Date:12/14/2019)... ... December 10, 2019 , ... A ... yeasts derived from food are able to reduce the virulence of, and even ... in hospitalized and immune-compromised individuals, including the multi-drug resistant Candida auris, which was ...
Breaking Biology News(10 mins):